-
Forward Look
Upfront Immunotherapy in Early-stage Liver CancerResearchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.
by Christina Szalinski
-
Forward Look
The Overlooked Issue of Hearing LossStudy underscores importance of regular hearing tests for those who receive cisplatin chemotherapy.
by Risa Kerslake
-
Overcoming ResistancePeople with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
by Kendall K. Morgan
-
Survivor Profile
A Pediatric Cancer Survivor Helps Kids CopeEthan Schilling was treated for a brain tumor at age 12. Now a psychologist, he helps children find the tools to adjust to a new reality after cancer.
by Sharon Tregaskis
-
Q&A
A Journey of Self-discoveryKailee McGee’s short film explores how a breast cancer diagnosis reshaped how she sees herself.
by Tyler Santora
-
Get Involved
Stitching SupportFourteen-year-old Giuliana Demma sews colorful hospital gowns for children receiving cancer treatment.
by Thomas Celona
-
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
-
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
